News
SERB Specialty Pharmaceuticals has purchased BTG Specialty Pharmaceuticals, a division of Boston Scientific that develops treatments with critical...
A single dose of the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine reduces UK hospitalisations in over-80s by 80%, a Public Health England study...
Cancer Research UK and Teon Therapeutics have entered a collaboration agreement to progress the early phase clinical development of...
CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), has received a grant from innovation agency Innovate UK to...
Iktos has announced that its artificial intelligence (AI) technology for de novo design will be applied to selected Pfizer small-molecule discovery...
German science and technology company Merck have agreed a worldwide in-licensing agreement with Debiopharm for the development and commercialisation...
Oasmia Pharmaceutical, an innovation-focused specialty pharmaceutical company, is set to acquire exclusive global development rights for Kazia...
Evotec and Chinook Therapeutics have agreed a deal to discover and develop new therapies for patients with chronic kidney diseases (CKD).
The FDA has issued emergency use authorisation for Johnson & Johnson’s one-shot COVID-19 vaccine, approving the jab for use in individuals aged...
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for Ipsen’s Cabometyx (cabozantinib) in combination with...